We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
T2 Biosystems Inc | NASDAQ:TTOO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.145 | 4.32% | 3.50 | 3.25 | 3.43 | 162 | 10:51:23 |
Management is scheduled to present Thursday, February 27, 2020 at 11:00am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the company’s website at www.t2biosystems.com.
About T2 Biosystems T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, the T2Bacteria® Panel, and the T2Resistance™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including products for the detection of additional species and antibiotic resistance markers of sepsis pathogens, and tests for Lyme disease.
Media Contact: Gina Kent, Vault Communications gkent@vaultcommunications.com 610-455-2763
Investor Contact: Philip Trip Taylor, Gilmartin Group philip@gilmartinIR.com 415-937-5406
1 Year T2 Biosystems Chart |
1 Month T2 Biosystems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions